Keurig Dr Pepper Inc (KDP)

Investment Committee Summary

Investment Thesis

At $32.51 on 25 August 2026 Keurig Dr Pepper trades near 13x forward earnings, roughly half the multiple of its large-cap beverage peers. The tape prices it as a slow-growth beverage house whose volume base is exposed to appetite-suppressant substitution and private label, with a heavy debt load capping the rating: the balance sheet carries net debt of ~$24.8B, which is the single largest difference between this name and the peers it is compared against. The engine only partly accepts the discount. Triangulated fair value is $22.95, -29% against spot, so the shares are trading rich to the blended evidence even at a peer-relative discount, with a probability-weighted value of $31.16 and a 12-month target of $31.46; the rating is HOLD. The reason is that the multiple, not the earnings line, drives most of the Monte Carlo dispersion, which makes this a re-rating debate rather than an earnings-collapse debate, while the independent capital-spending-bridge discounted cash flow anchors far beneath the market because leverage is charged in full against a segment operating margin near 23%. Cheap on a multiple, unproven on volume, over-levered on the balance sheet. The single most damaging risk is a sustained structural volume decline that turns the discount into a value trap rather than an entry point.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($32.51) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear is the structural volume path, and its mechanism is not a one-year air pocket but a permanent step-down in per-capita consumption of sweetened and caffeinated beverages as appetite-suppressant drugs scale and retailers push their own labels. Volume turns persistently negative, price and mix can no longer offset it, and the operating margin drifts down from 23% as promotional intensity rises. The multiple then de-rates from an already low 13x toward a private-label floor. Crucially, net debt of ~$24.8B magnifies the equity damage: enterprise value falls against a fixed liability, so a given decline in operating value takes a proportionally larger bite out of the equity. On that path the target lands below the 52-week low, which is the honest structural outcome rather than a token hedge.

Key Debate

P/E Multiple explains 65% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 14.2× consensus forward EPS, vs the house DCF terminal 11.0×, and a peer median 24.8×. The house DCF sits 54% below spot, so the market is pricing in more than the house case — roughly 2.7pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — GLP-1 Volume Hit / De-Rate' downside ($14.60) to a 'Bull — Defensive Re-Rate' bull case ($48.90); the probability-weighted blend (PWEV $31.16) is -4% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.6% of revenue; free cash flow net of SBC is $1.41B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — GLP-1 Volume Hit / De-Rate (20%, $14.60). Structural impairment — GLP-1 volume hit / de-rate: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Consumer / Input Recession (17%, $24.90). Cyclical downturn — beverage volume + pricing/mix + emerging-market growth (GLP-1 debate) weakens for 1–2 years before normalising.
• Base — Pricing + Mix Growth (35%, $33.20). Mid-cycle — normalised beverage volume + pricing/mix + emerging-market growth (GLP-1 debate); disciplined capital allocation; steady returns.
• Growth — Emerging Markets + Energy/Zero-Sugar (20%, $42.40). Upside — emerging markets + energy / zero-sugar lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Defensive Re-Rate (8%, $48.90). Upside tail — sustained tight conditions or a structural re-rate on emerging markets + energy / zero-sugar.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $28.13 + scenario PWEV $31.16, ≈ spot); the weighted blend $22.95 (-29%) sits below it because the cash-flow DCF ($14.85) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $28.13 and 35% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (65% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 7.0%, 11.0x terminal FCF multiple → $14.85. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $79.09; the peer-median forward P/E is 24.8x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 206% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Non-Alcoholic Beverages multiple (AI re-rating) (base 13.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 21.9× (simple median 24.8×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $24.43–$34.77, centre $29.10 (-10% vs spot); spot sits at the 78th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Defensive Re-Rate): $48.90.

Company Overview & Business Model

Keurig Dr Pepper Inc — CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC. Keurig Dr Pepper Inc. is a beverage company in the United States and internationally. The company is headquartered in Burlington, Massachusetts.

How it makes money.

Edge. Narrow moat — KDP's distribution/route-to-market scale and a few #1 brands support a narrow moat that justifies only a mid-teens multiple, not a KO/PEP premium; the falsifiable claim is that if US Refreshment Beverages volume runs persistently negative (private-label + GLP-1 substitution), the moat is failing and the terminal multiple should compress toward the ~7-8x private-label floor rather than the ~13x base.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 96% — cash-backed.

Competitive Moat

Moat sources:

• Direct-store-delivery cold-drink distribution scale and shelf access (a real but contestable route-to-market advantage)
• #1 US coffee (single-serve Keurig razor/blade installed base) and a handful of leading CSD/flavour brands (Dr Pepper, Canada Dry)
• NO data/platform moat and limited pricing power vs a resurgent, higher-quality private label
• Scale in procurement and manufacturing that narrows unit-cost gaps but does not confer category dominance

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.45 vs analyst floor +0.01 → delta +0.44 (n=14 mgmt / 7 Q&A; 57th pctile across the S&P book, z +0.2).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1325 articles): avg ticker sentiment +0.19 (bullish 21% / bearish 2%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2027-02-24 (~184d) — FY2027 guidance / capital-allocation update (deleveraging path) (authored)

Forecast Track Record

• EPS surprise: beat 62% of the last 8 quarters; average surprise +4.1%.
• Prior-forecast backtest (11 snapshots, 2026-06-26→2026-08-20): directional hit-rate 91%; mean predicted +2.1% vs realised +5.6%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

4 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Constant-currency net sales growth (y/y) < 0.015 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• U.S. Refreshment Beverages volume (y/y) < -0.03 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Gross margin (y/y change, bps) < -150 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Net debt / EBITDA (turns) > 3.5 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Full-year adjusted EPS guidance revision < 0.0 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $32.51; 52-week range $24.43–$34.77; engine rating HOLD; house target $31.46 (-3%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $22.95 (-29% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

53.7/100 (confidence band 41.1–66.2), 32nd percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 54.1 → 54.1 → 52.6 → 51.4 → 51.4 → 54.0 → 53.9 → 53.9.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $31.16.

Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.11, vs QQQ +0.03 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• range-bound with fair premium — harvest income against a holding
• Direction neutral from the overlay conviction/rating (read-only input).
• IV/RV at the 33rd percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 62nd percentile of its own month-end history (decile 7).
• IV term structure is in contango (longer-dated richer, slope +6.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +6.8pp): 25-DTE 22% · 116-DTE 25% · 389-DTE 29%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 22.0% (subdued regime) · expected move ±4.5% (2026-09-18) · put/call OI 0.45 · ATM Δ 0.42 / Θ -0.02 / ν 0.03. Direction: NEUTRAL (implied return -29.4% to triangulated fair value $22.95).

Covered Call (if held) (Income / neutral) — Short 35 C · 2026-09-18 · premium $0.4 · yield 1.2% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 30 P / Long 28 P · 2026-10-16 · net $0.13 · net entry $29.88 · yield 0.4% · RoR 7.0% · max loss $1.88 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 29 P / Short 36 C · 2027-03-19 · net $0.12 · floor -11.0% · cap +11.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies -4% vs spot
• Monte Carlo median implies -13% vs spot
• DCF fair value implies -54% vs spot — but this is terminal-value sensitive (exit-multiple $14.85 vs Gordon $39.57, 166% apart), so it carries less weight
• Bear case (Structural — GLP-1 Volume Hit / De-Rate) downside is -55% vs spot
• Net: the valuation anchor itself sits 29.4% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 5% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 7.0% · Σ PV(FCF) $14B + PV(terminal) $31B = EV $44B; − net debt $24.8B → equity $20B ÷ diluted shares $1.32B = $14.85/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $39.57/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 16% vs WACC 7.0% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $79.09 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (9.0); Op margin ±3pp (9.0); Terminal × ±15% (7.0); WACC ±1pp (3.0); Capex intensity ±15% (3.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 7.0%, terminal multiple 11×, FY+5 revenue $21B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.